Close Menu

NEW YORK (GenomeWeb) – The GenomeWeb Index climbed nearly 4 percent in March driven by rising stock prices for Natera, Veracyte, and Fluidigm.

Overall, 22 of the 30 stocks that comprise the index saw increases. The 4 percent gain also beat the broader markets last month with the Dow Jones Industrial average essentially flat month over month, while the Nasdaq Composite grew almost 3 percent, and the Nasdaq Biotech was down about 1 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.